Optimizing Hydrophilic Drug Incorporation into SEDDS Using Dry Reverse Micelles: a Comparative Study of Preparation Methods

Overview

Journal Drug Deliv Transl Res

Publisher Springer

Date 2025 Jan 17

PMID 39821869

Authors

Sera Lindner

Fabrizio Ricci

Matthias Sandmeier

Rene Holm

Cecilia Bohns Michalowski

Nathaniel Washburn

Dajun Sun

Giustino Di Pretoro

Andreas Bernkop-Schnurch

Affiliations

Soon will be listed here.

Abstract

Aim: It was the aim of this study to compare two different dry reverse micelle (RM) preparation methods for the incorporation of hydrophilic drugs into oral self-emulsifying drug delivery systems (SEDDS).

Methods: Cationic ethacridine lactate, anionic fluorescein sodium salt and the antibiotic peptide bacitracin were solubilized in RM containing sodium docusate, soy phosphatidylcholine and sorbitan monooleate in highly lipophilic oils such as squalane. In the dry addition (DA) method, drugs were directly added to empty RM in their powder form. In the organic solvent-aided (OS) method, drugs were pre-dissolved in ethanol or 2-propanol, which were then evaporated to form loaded dry RM.

Results: RM with sorbitan monooleate prepared via the DA method yielded up to 2.7-fold higher solubility only for bacitracin compared to the OS method. In contrast, OS-RM with sodium docusate and soy phosphatidylcholine exhibited significantly higher drug solubilities, achieving up to 109-fold, 44-fold and 97-fold increase for ethacridine, fluorescein and bacitracin, respectively. For all model drugs, the logD was highest for RM comprising sorbitan monooleate, with a slight increase for OS-RM. This was consistent with the release profiles from SEDDS, showing an enhanced retention when loaded with OS-RM. While DA-RM showed no significant difference in cellular uptake, it was 1.6-fold higher in OS-RM loaded squalane-based SEDDS.

Conclusion: The DA method is an easier approach for incorporating hydrophilic drugs into dry RM. However, the OS method presents a more promising alternative as it significantly enhanced the solubility and retention of these drugs in highly lipophilic formulations.

References

Goldberg M, Gomez-Orellana I . Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov. 2003; 2(4):289-95. DOI: 10.1038/nrd1067. View

Maher S, Mrsny R, Brayden D . Intestinal permeation enhancers for oral peptide delivery. Adv Drug Deliv Rev. 2016; 106(Pt B):277-319. DOI: 10.1016/j.addr.2016.06.005. View

Drucker D . Advances in oral peptide therapeutics. Nat Rev Drug Discov. 2019; 19(4):277-289. DOI: 10.1038/s41573-019-0053-0. View

Pereira de Sousa I, Bernkop-Schnurch A . Pre-systemic metabolism of orally administered drugs and strategies to overcome it. J Control Release. 2014; 192:301-9. DOI: 10.1016/j.jconrel.2014.08.004. View

Mahmood A, Bernkop-Schnurch A . SEDDS: A game changing approach for the oral administration of hydrophilic macromolecular drugs. Adv Drug Deliv Rev. 2018; 142:91-101. DOI: 10.1016/j.addr.2018.07.001. View

Hetenyi G, Griesser J, Moser M, Demarne F, Jannin V, Bernkop-Schnurch A . Comparison of the protective effect of self-emulsifying peptide drug delivery systems towards intestinal proteases and glutathione. Int J Pharm. 2017; 523(1):357-365. DOI: 10.1016/j.ijpharm.2017.03.027. View

Griesser J, Hetenyi G, Kadas H, Demarne F, Jannin V, Bernkop-Schnurch A . Self-emulsifying peptide drug delivery systems: How to make them highly mucus permeating. Int J Pharm. 2018; 538(1-2):159-166. DOI: 10.1016/j.ijpharm.2018.01.018. View

Ristroph K, Prudhomme R . Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers. Nanoscale Adv. 2021; 1(11):4207-4237. PMC: 7771517. DOI: 10.1039/c9na00308h. View

Gamboa A, Schussler N, Soto-Bustamante E, Romero-Hasler P, Meinel L, Morales J . Delivery of ionizable hydrophilic drugs based on pharmaceutical formulation of ion pairs and ionic liquids. Eur J Pharm Biopharm. 2020; 156:203-218. DOI: 10.1016/j.ejpb.2020.09.007. View

10.

Griesser J, Hetenyi G, Moser M, Demarne F, Jannin V, Bernkop-Schnurch A . Hydrophobic ion pairing: Key to highly payloaded self-emulsifying peptide drug delivery systems. Int J Pharm. 2017; 520(1-2):267-274. DOI: 10.1016/j.ijpharm.2017.02.019. View

11.

Chamieh J, Domenech Tarrat A, Doudou C, Jannin V, Demarne F, Cottet H . Peptide release from SEDDS containing hydrophobic ion pair therapeutic peptides measured by Taylor dispersion analysis. Int J Pharm. 2019; 559:228-234. DOI: 10.1016/j.ijpharm.2019.01.039. View

12.

Correa N, Silber J, Riter R, Levinger N . Nonaqueous polar solvents in reverse micelle systems. Chem Rev. 2012; 112(8):4569-602. DOI: 10.1021/cr200254q. View

13.

Urano R, Pantelopulos G, Straub J . Aerosol-OT Surfactant Forms Stable Reverse Micelles in Apolar Solvent in the Absence of Water. J Phys Chem B. 2019; 123(11):2546-2557. DOI: 10.1021/acs.jpcb.8b07847. View

14.

Stella V . Prodrugs: Some thoughts and current issues. J Pharm Sci. 2010; 99(12):4755-65. DOI: 10.1002/jps.22205. View

15.

Matzke S, Creagh A, Haynes C, Prausnitz J, Blanch H . Mechanisms of protein solubilization in reverse micelles. Biotechnol Bioeng. 1992; 40(1):91-102. DOI: 10.1002/bit.260400114. View

16.

Vrignaud S, Anton N, Gayet P, Benoit J, Saulnier P . Reverse micelle-loaded lipid nanocarriers: a novel drug delivery system for the sustained release of doxorubicin hydrochloride. Eur J Pharm Biopharm. 2011; 79(1):197-204. DOI: 10.1016/j.ejpb.2011.02.015. View

17.

Matteo Jorgensen A, Steinbring C, Stengel D, To D, Schmid P, Bernkop-Schnurch A . Self-Emulsifying Drug Delivery Systems (SEDDS) Containing Reverse Micelles: Advanced Oral Formulations for Therapeutic Peptides. Adv Healthc Mater. 2023; 12(31):e2302034. PMC: 11468804. DOI: 10.1002/adhm.202302034. View

18.

Vrignaud S, Hureaux J, Wack S, Benoit J, Saulnier P . Design, optimization and in vitro evaluation of reverse micelle-loaded lipid nanocarriers containing erlotinib hydrochloride. Int J Pharm. 2012; 436(1-2):194-200. DOI: 10.1016/j.ijpharm.2012.06.026. View

19.

Wainwright M . Acridine-a neglected antibacterial chromophore. J Antimicrob Chemother. 2001; 47(1):1-13. DOI: 10.1093/jac/47.1.1. View

20.

Mascher T, Margulis N, Wang T, Ye R, Helmann J . Cell wall stress responses in Bacillus subtilis: the regulatory network of the bacitracin stimulon. Mol Microbiol. 2003; 50(5):1591-604. DOI: 10.1046/j.1365-2958.2003.03786.x. View